New Technologies Shed Light on Caveolae

The functions of the cellular invaginations identified more than half a century ago are now beginning to be understood in detail.

Written byBen Nichols
| 12 min read

Register for free to listen to this article
Listen with Speechify
0:00
12:00
Share

© ANDREIUC88/SHUTTERSTOCK.COMIn 1953, cell biologist George Palade used the recently developed technique of electron microscopy to examine the surface of the endothelial cells that form blood vessels. He saw in these mammalian cells that the plasma membrane, which forms the outer barrier of all cell types, was riddled with invaginations.1 The appearance of these folded structures was remarkable: uniformly flask-shape, they self-associated to form intricate, interconnected arrays.

Two years later, Japanese electron microscopist Eichi Yamada coined the term “caveolae,” from the Latin for “little caves,” to describe these invaginations. Caveolae have since turned up in several cell types, accounting for nearly half of all the plasma membrane surface of fat cells as well as endothelial cells. Yet more than half a century after Palade’s discovery, a complete understanding of the cellular function of caveolae remains frustratingly elusive.

One thing that is clear is that genetic data show caveolae to be important for the normal function of blood vessels, muscle, and fat tissue. But how, in precise molecular terms, caveolae contribute to the health of these tissues is still open to debate.

Several models to explain exactly what caveolae are doing have been ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

June 2018

Microbial Treasure

Newly discovered archaea reveal bizarre biology

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies